These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15508391)

  • 1. What is in the QSR/GMP?
    Bartoo G;
    IEEE Eng Med Biol Mag; 2004; 23(4):83-5. PubMed ID: 15508391
    [No Abstract]   [Full Text] [Related]  

  • 2. The IVD directive: late-phase practicalities.
    Johnson P; Walker R
    Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
    [No Abstract]   [Full Text] [Related]  

  • 3. How to kick-start your CAPA process.
    Peterson K
    Biomed Instrum Technol; 2005; 39(1):55-9. PubMed ID: 15742850
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrating risk management into the CAPA process.
    Bills E; Tartal J
    Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
    [No Abstract]   [Full Text] [Related]  

  • 5. What is the QSR/GMP, and why should you care?
    Bartoo G
    IEEE Eng Med Biol Mag; 2004; 23(2):98-9. PubMed ID: 15264479
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementing new European vigilance procedures.
    Donawa M
    Med Device Technol; 2007; 18(7):34, 36-7. PubMed ID: 18075133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective risk management programmes.
    Donawa M
    Med Device Technol; 2004 May; 15(4):28-30. PubMed ID: 15303561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the Medical Device Directive.
    Donawa M
    Med Device Technol; 2003 Mar; 14(2):20-3. PubMed ID: 12698694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European medical device regulation: a new era?
    Donawa M
    Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful recruitment for medical device clinical studies.
    Donawa M
    Med Device Technol; 2004 Oct; 15(8):25-7. PubMed ID: 16225270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the US submisson process.
    Donawa M
    Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The US medical device bundling policy.
    Donawa M
    Med Device Technol; 2004 Nov; 15(9):25-7. PubMed ID: 16231784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVD authorized representatives.
    Donawa ME
    Med Device Technol; 2003 May; 14(4):19-21. PubMed ID: 12774572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Animal Tissue Directive.
    Donawa M
    Med Device Technol; 2004; 15(1):28-31. PubMed ID: 14994636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk management.
    Bartoo G
    IEEE Eng Med Biol Mag; 2003; 22(4):166-70, 172. PubMed ID: 14515712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marketing a medical device without a 510(k).
    Munzner R
    IEEE Eng Med Biol Mag; 2003; 22(5):133. PubMed ID: 14699948
    [No Abstract]   [Full Text] [Related]  

  • 19. US and European postmarket clinical data requirements.
    Donawa M
    Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory reticence and medical devices.
    Fox DM; Zuckerman DM
    Milbank Q; 2014 Mar; 92(1):151-9. PubMed ID: 24597559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.